USD 1.6
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 506.53 Thousand USD | 934.55% |
2022 | 48.96 Thousand USD | -28.05% |
2021 | 68.05 Thousand USD | 3166.83% |
2020 | -2219.00 USD | 95.92% |
2019 | -54.38 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -37.91 Thousand USD | -2635.43% |
2024 Q1 | -1386.00 USD | -102.83% |
2023 Q2 | 47.08 Thousand USD | 13.38% |
2023 Q3 | 48.95 Thousand USD | 3.97% |
2023 FY | 49 Thousand USD | 0.08% |
2023 Q1 | 41.53 Thousand USD | -15.18% |
2023 Q4 | 49 Thousand USD | 0.09% |
2022 Q3 | 44.36 Thousand USD | -39.2% |
2022 FY | 48.96 Thousand USD | -28.05% |
2022 Q4 | 48.96 Thousand USD | 10.35% |
2022 Q2 | 72.97 Thousand USD | 3.59% |
2022 Q1 | 70.44 Thousand USD | 3.51% |
2021 Q4 | 68.05 Thousand USD | 86.85% |
2021 Q1 | -1085.00 USD | 51.1% |
2021 FY | 68.05 Thousand USD | 3166.83% |
2021 Q2 | 13.74 Thousand USD | 1366.54% |
2021 Q3 | 36.42 Thousand USD | 165.04% |
2020 FY | -2219.00 USD | 95.92% |
2020 Q4 | -2219.00 USD | 0.0% |
2020 Q1 | 54.38 Thousand USD | 0.0% |
2019 FY | -54.38 Thousand USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Cell MedX Corp. | 244.05 Thousand USD | -107.553% |